Sweden · 
Who invested in PharmNovo?
PharmNovo's investors include EIC Accelerator and Almi Invest.
Sweden · Venture startup
Who invested in PharmNovo
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2024, from 1 source
- Latest round
- Venture, $16MJul 2024
- Investors
- 2
The rounds
- Jul 2024
Founders and team
From PharmNovo's own website: 12 on the team.
- Per von MentzerChief executive officer
- Alexander DahlquistChief financial officer
- David KendallChief scientific officer
- Jarkko KalliomäkiMD, Clinical lead and CMO
- Jesper KjerulffProject lead and COO
- Agusta GudjonsdottirRegulatory lead
- Carl-Magnus AnderssonChemistry lead
- Marianne SvärdCMC sub-team lead
- Olof BreuerMD, Clinical pharmacology lead
- Petra LarsonCommunications lead
- Rikke WintherClinical outsourcing lead
- Stefan IngelssonSenior clinical trial manager
AdvisersBengt von MentzerKerstin Kenne
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about PharmNovo
How much has PharmNovo raised?
PharmNovo has raised $16M across 1 round since 2024.
When did PharmNovo last raise?
PharmNovo's most recent round was a Venture of $16M in Jul 2024.
What was PharmNovo's biggest round?
Its most recent round, $16M in Jul 2024, is also its largest on record.
Who backed PharmNovo first?
PharmNovo's first round on record, in Jul 2024, was backed by EIC Accelerator and Almi Invest.
What stage is PharmNovo at?
PharmNovo's latest named round is a Venture, in Jul 2024.
Where is PharmNovo based?
PharmNovo is based in Sweden.
Companies like PharmNovo
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.